Twentyeight Seven announced it raised $60.8 Million in an amended filing from an offering of $76.9 Million

Company

Location

About

Previous name of Redona Therapeutics, Inc. is Twentyeight-Seven, Inc. Redona Therapeutics is focused on the modulation of functional non-coding RNA (ncRNA) to treat cancer and other human diseases. By targeting ncRNA modulating proteins (RMPs), we can use small molecules to modulate expression levels of oncogenes and other proteins of significance in disease.